Search Articles — Sudonull

Search Results

In this project

Japan joins $1 billion AI project Genesis Mission: what it means

https://sudonull.com/japan-joins-1-billion-ai-project-genesis-mission-what-it-means

Japan invests $500 million in US AI project Genesis Mission. We analyze the goals, benefits for the parties, and hidden risks of the technological cold war with China. Read the analysis.

Generative UI: three approaches for AI

https://sudonull.com/generative-ui-three-approaches-for-ai

Breakdown of three GenUI strategies: from HTML to Tambo. When to apply, pros-cons, comparison. For product managers and designers — implement adaptive interfaces without chaos.

CRISPR-pencil: gene therapy N=1 saved an infant

https://sudonull.com/crispr-pencil-gene-therapy-n-1-saved-an-infant

Doctors edited a newborn's liver by assembling therapy for a unique mutation. Learn how CRISPR-pencil is changing regulation and the future of medicine.

Reqorsa Gene Therapy: Analysis of ASCO-2026 Data and Prospects

https://sudonull.com/reqorsa-gene-therapy-analysis-of-asco-2026-data-and-prospects

Critical analysis of Reqorsa gene therapy results at ASCO-2026: sample of 18 patients, p=0.05, risks for investors and the real situation of Genprex. Read details.

Image generation by references without text

https://sudonull.com/image-generation-by-references-without-text

Learn how to replace text prompts with references for precise AI art generation. Comparison of arena.ai models, post-processing pipeline. Save time on projects — read the guide for designers.

From other projects

Cardiologist Topol debunks myths of the anti-aging industry

https://ymaho.com/cardiologist-topol-debunks-myths-of-the-anti-aging-industry

Eric Topol proved: there are no longevity genes, and the $85 billion anti-aging market is overvalued. Find out why lifestyle and AI prevention are more important than peptides and cryochambers.

Smart drugs for cancer and HIV: development by Siberian scientists

https://ymaho.com/smart-drugs-for-cancer-and-hiv-development-by-siberian-scientists

Institute of the Siberian Branch of the Russian Academy of Sciences creates therapeutic oligonucleotides — molecules that switch off cancer and HIV genes. The development of phosphorylguanidines promises treatment without side effects. Learn how Russian genetic engineering bypasses Western patents.

RNA editing with light: CRISPR/Cas13d for deep tissues

https://ymaho.com/rna-editing-with-light-crispr-cas13d-for-deep-tissues

Scientists created a photoactivatable system paCas13d with nanoparticles. The technology cured bone necrosis in mice without harming systemic therapy. Learn how IR light controls genes at tissue depth.

FDA approved the first gene therapy for hereditary deafness

https://ymaho.com/fda-approved-the-first-gene-therapy-for-hereditary-deafness

Regeneron's Otarmeni restores hearing to normal in 42% of patients. The therapy treats OTOF gene mutations with a single injection. Learn how AAV vector technology has for the first time restored the ability to hear a whisper.

Gene therapy against aging: Russian RNA drugs block RAGE

https://ymaho.com/gene-therapy-against-aging-russian-rna-drugs-block-rage

Scientists from Russia are creating the world's first gene therapeutic drug for aging: a RAGE gene blocker and exosomes against sarcopenia. Learn how the state project promises to restore muscles and prolong active life.

Gene therapy of aging in the Russian Federation: RAGE blockade and sarcopenia exosomes

https://ymaho.com/gene-therapy-of-aging-in-the-russian-federation-rage-blockade-and-sarcopenia-exosomes

Russian scientists are creating the world's first anti-aging drugs: RAGE gene blocker and exosome rejuvenation. The Ministry of Education and Science promises clinical use by 2030. Learn how transplantation of 'young' vesicles restores muscles and why the budget exceeds 2 trillion rubles.

Trending Now